Skip to content

Optimizing the Previs Device for Prediction of Postoperative Ileus

Optimizing the Previs Device for Prediction of Postoperative Ileus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03505476
Enrollment
203
Registered
2018-04-23
Start date
2018-04-24
Completion date
2023-06-05
Last updated
2025-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileus

Keywords

Ileus, Abdominal surgery, Bowel obstruction, Postoperative Ileus

Brief summary

The research proposed in this study will develop a noninvasive prototype device that will capture intestinal sounds, process signals, and display predictive information in real-time at the point-of-care using algorithms already developed at this institution.

Detailed description

Following major abdominal surgery, up to 30% of patients develop a poorly understood condition known as ileus. When ileus occurs, the bowels shut down and patients often develop abdominal dissension, nausea, vomiting, and even more serious complications. Because this condition does not develop until many days after surgery has been completed, clinicians do not know if they should begin allowing patients to eat or withhold nutrition until they show signs of bowel function such as passing gas or having bowel movements. Clinicians have different approaches but none are ideal: 1) feed all patients early and the ones that develop an ileus will have their diets reverse, suction tube placed in their stomach, and hopefully don't get develop more serious complications, or 2) don't feed patients until they pass gas or have a bowel movement, which delays nutrition and prolongs hospital stays for the 70% of patients who will not develop an ileus Participants in this study will be asked to wear a 3-ounce device that adheres to the skin of the abdominal wall for 10 days. They will also be asked to answer questions each day of their hospital stay regarding how they have tolerated eating.

Interventions

DEVICEEntac Medical device application

Subjects will wear a 3-inch by 3-inch stethoscope device that adheres to the skin of the abdomen via FDA approved adhesive material. It will be applied either in the operating room at the completion of surgery or in the recovery room. The device will remain on the abdomen until discharge or for 10 days, whichever comes first.

OTHERPatient Daily Assessment

The research team will ask questions of the subject regarding nausea, vomiting, passage of flatus, return of bowel function, and satisfaction with the device every day that the subject is hospitalized.

OTHERPatient Discharge Assessment

The research team will ask questions of the subject regarding satisfaction or dissatisfaction with having the device placed and attached to their abdomen.

Sponsors

Jennifer Hrabe
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

All subjects consented and enrolled will receive the same intervention. There is no control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Patients undergoing elective intestinal resection surgery by the colorectal surgery service at UIHC. Age 18 to 100.

Exclusion criteria

Allergies to any of the device components. Inability to have prototype device applied to their abdominal wall due to a condition (ie:fistulas, stomas, drains, etc).

Design outcomes

Primary

MeasureTime frameDescription
Device Sensitivity for Predicting Ileus.Each patient's device's data was assessed at day 15.Calculate the sensitivity of the device to predict ileus, as defined by the number of patients with device-predicted ileus (true positive) as compared to the number both with device-predicted ileus and with ileus that the device did not predict (true positive + false negative).
Device Specificity for Predicting IleusEach patient's device's data was assessed at day 15.Calculate the specificity of the device to predict ileus, as defined by the number of patients where the device correctly predicted no ileus (true negative) as compared to the number both with device correctly predicting no ileus and device incorrectly predicting ileus (true negative plus false positive).
Device Positive Predictive Value for Predicting IleusEach patient's device's data was assessed at day 15.Calculate the positive predictive value of the device to predict ileus, as defined by the number of patients with device-predicted ileus (true positive) as compared to the number both with device-predicted ileus and with device incorrectly predicting ileus (true positive plus false positive).
Device Negative Predictive Value for Predicting IleusEach patient's device's data was assessed at day 15.Calculate the negative predictive value of the device to predict ileus, as defined by the number of patients where the device correctly predicted no ileus (true negative) as compared to the number both with device correctly predicted no ileus and with ileus the device did not predict (true negative plus false negative).

Countries

United States

Participant flow

Participants by arm

ArmCount
Study Participants
Device: Entac Medical device application Other: Patient Daily Assessment Other: Patient Discharge Assessment Entac Medical device application: Subjects will wear a 3-inch by 3-inch stethoscope device that adheres to the skin of the abdomen via FDA approved adhesive material. It will be applied either in the operating room at the completion of surgery or in the recovery room. The device will remain on the abdomen until discharge or for 10 days, whichever comes first. Patient Daily Assessment: The research team will ask questions of the subject regarding nausea, vomiting, passage of flatus, return of bowel function, and satisfaction with the device every day that the subject is hospitalized. Patient Discharge Assessment: The research team will ask questions of the subject regarding satisfaction or dissatisfaction with having the device placed and attached to their abdomen.
203
Total203

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyData Corrupt6
Overall StudyDevice application insufficiant3
Overall StudyDevice Malfunctioned101
Overall StudyPhysician Decision18

Baseline characteristics

CharacteristicStudy Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
64 Participants
Age, Categorical
Between 18 and 65 years
139 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
197 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
195 Participants
Region of Enrollment
United States
203 participants
Sex: Female, Male
Female
108 Participants
Sex: Female, Male
Male
95 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 203
other
Total, other adverse events
0 / 203
serious
Total, serious adverse events
0 / 203

Outcome results

Primary

Device Negative Predictive Value for Predicting Ileus

Calculate the negative predictive value of the device to predict ileus, as defined by the number of patients where the device correctly predicted no ileus (true negative) as compared to the number both with device correctly predicted no ileus and with ileus the device did not predict (true negative plus false negative).

Time frame: Each patient's device's data was assessed at day 15.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Study ParticipantsDevice Negative Predictive Value for Predicting IleusPatients with ileus whose device predicted ileus (true positive)12 Participants
Study ParticipantsDevice Negative Predictive Value for Predicting IleusPatients without ileus whose device predicted ileus (false positive)22 Participants
Study ParticipantsDevice Negative Predictive Value for Predicting IleusPatients with ileus whose device did not predict ileus (false negative)2 Participants
Study ParticipantsDevice Negative Predictive Value for Predicting IleusPatients without ileus whose device did not predicted ileus (true negative)39 Participants
Primary

Device Positive Predictive Value for Predicting Ileus

Calculate the positive predictive value of the device to predict ileus, as defined by the number of patients with device-predicted ileus (true positive) as compared to the number both with device-predicted ileus and with device incorrectly predicting ileus (true positive plus false positive).

Time frame: Each patient's device's data was assessed at day 15.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Study ParticipantsDevice Positive Predictive Value for Predicting IleusPatients with ileus whose device predicted ileus (true positive)12 Participants
Study ParticipantsDevice Positive Predictive Value for Predicting IleusPatients with ileus whose device did not predict ileus (false negative)2 Participants
Study ParticipantsDevice Positive Predictive Value for Predicting IleusPatients without ileus whose device predicted ileus (false positive)22 Participants
Study ParticipantsDevice Positive Predictive Value for Predicting IleusPatients without ileus whose device did not predicted ileus (true negative)39 Participants
Primary

Device Sensitivity for Predicting Ileus.

Calculate the sensitivity of the device to predict ileus, as defined by the number of patients with device-predicted ileus (true positive) as compared to the number both with device-predicted ileus and with ileus that the device did not predict (true positive + false negative).

Time frame: Each patient's device's data was assessed at day 15.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Study ParticipantsDevice Sensitivity for Predicting Ileus.Patients with Ileus whose device predicted ileus (true positive).12 Participants
Study ParticipantsDevice Sensitivity for Predicting Ileus.Patients with ileus whose device did not predict ileus (false negative).2 Participants
Study ParticipantsDevice Sensitivity for Predicting Ileus.Patients without ileus whose device predicted ileus (false positive).22 Participants
Study ParticipantsDevice Sensitivity for Predicting Ileus.Patients without ileus whose device did not predict ileus (true negative).39 Participants
Primary

Device Specificity for Predicting Ileus

Calculate the specificity of the device to predict ileus, as defined by the number of patients where the device correctly predicted no ileus (true negative) as compared to the number both with device correctly predicting no ileus and device incorrectly predicting ileus (true negative plus false positive).

Time frame: Each patient's device's data was assessed at day 15.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Study ParticipantsDevice Specificity for Predicting IleusPatients without ileus whose device did not predict ileus (true negative)39 Participants
Study ParticipantsDevice Specificity for Predicting IleusPatients with ileus whose device predicted ileus (true positive)12 Participants
Study ParticipantsDevice Specificity for Predicting IleusPatients with ileus whose device did not predict ileus (false negative)2 Participants
Study ParticipantsDevice Specificity for Predicting IleusPatients without ileus whose device predicted ileus (false positive)22 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026